Trial Profile
An Exploratory, Open Label, Fixed Sequence Study To Investigate The Pharmacokinetics Of Single Intravenous And Oral Micro Doses Of PF-06273588 In Healthy Male Subjects
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 19 Oct 2015
Price :
$35
*
At a glance
- Drugs PF 6273588 (Primary) ; PF 6273588 (Primary)
- Indications Mood disorders
- Focus Adverse reactions; Pharmacokinetics
- Sponsors Pfizer
- 08 Sep 2011 Actual end date (August 2011) added as reported by ClinicalTrials.gov.
- 08 Sep 2011 Actual initiation date (July 2011) added as reported by ClinicalTrials.gov.
- 08 Sep 2011 Status changed from not yet recruiting to completed as reported by ClinicalTrials.gov.